Newsroom | 2392 results

Sorted by: Latest

Biometrics
-

Anthem Establishes Coverage of C2N Diagnostics’ PrecivityAD2® Blood Test for Alzheimer's Disease Evaluation

ST. LOUIS--(BUSINESS WIRE)--C2N Diagnostics, LLC ("C2N"), a specialty diagnostics company with a vision to bring Clarity Through Innovation®, announced that beginning October 1, 2026, eligible Anthem® Blue Cross® and Blue Shield® members will be the first in the United States to receive insurance coverage under a medical policy for the PrecivityAD2® blood test. This policy expands patient access to an innovative blood-based diagnostic test that helps health care professionals evaluate adults exp...
-

Retham Technologies Launches Functional Cryopreserved Platelets for Research; Prolytix Named Distributor of Retham Cryoplatelets™

WAUWATOSA, Wis.--(BUSINESS WIRE)--Retham Technologies announced the launch of its next-generation functional Retham Cryoplatelets™ and named Prolytix to be the distributor....
-

Thermo Fisher Scientific Receives First FBI Approval for Rapid DNA Crime Scene Profiles Eligible for National CODIS Searches

SAN FRANCISCO--(BUSINESS WIRE)--Thermo Fisher Scientific, the world leader in serving science, today announced that the Applied Biosystems™ RapidINTEL™ Plus Cartridge has received approval from the Federal Bureau of Investigation (FBI) National DNA Index System (NDIS) for use with qualifying forensic crime scene samples. The law enforcement milestone makes Thermo Fisher's Rapid DNA workflow on the RapidHIT ID™ System the first eligible to generate DNA profiles that can be searched against the n...
-

LinusBio Launches Traced™, the First Consumer Wellness Test to Track Environmental Exposures Over Time

NORTH BRUNSWICK, N.J.--(BUSINESS WIRE)--LinusBio launches Traced™, the first consumer wellness test that tracks environmental exposures over time....
-

AnyBio and Medplum Launch FHIR-Native Integration for Biosignal-Driven Care

SAN FRANCISCO--(BUSINESS WIRE)--AnyBio, the biosignal infrastructure platform for builders, and Medplum, the open-source FHIR-native developer platform, today announced a joint reference architecture for biosignal-driven care programs. The architecture is backed by a working integration over the FHIR Observation resource and a technical blog outlining how the two layers compose. The combination gives healthcare builders an end-to-end deployable stack - from wearable device to clinician workspac...
-

eClinical Solutions Advances Risk-Based Quality Management Solutions, Helping Sponsors Meet ICH E6(R3) Regulatory Guidelines

BOSTON--(BUSINESS WIRE)--eClinical Solutions LLC, a global provider of digital clinical software and services, today announced enhanced risk-based quality management (RBQM) features within the elluminate® Clinical Data Intelligence Platform. These advanced functionalities of elluminate RBQM, including access to improved administrative capabilities, cross-team collaboration functions, and workflow optimization, will improve processes across the clinical trial lifecycle, reduce fragmentation for...
-

HeartBeam Announces Strategic Shift to Accelerate Global Adoption of its Ambulatory ECG Signal Platform and Leadership Transition

SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Announces Strategic Shift to Accelerate Global Adoption of its Ambulatory ECG Signal Platform and Leadership Transition...
-

Entrust Takes on AI-Driven Account Takeover with a New Identity-Centric Approach to Authentication

MINNEAPOLIS--(BUSINESS WIRE)--Entrust helps prevent AI-driven account takeover with its Biometric Authentication solution. Verifying the real person behind high‑risk moments....
-

Global e·dentity™ Renews and Expands Exclusive Licensing Deal with SDS to $318 Million

CUPERTINO, Calif.--(BUSINESS WIRE)--Global e·dentity™ Inc., a Service-Disabled Veteran-Owned Small Business (SDVOSB), today announced the renewal and expansion of its exclusive licensing agreement with Supplier Development Systems LLC (SDS). The new five-year deal, valued at $318 million, extends SDS’s exclusive rights across Africa and adds Bahrain, Saudi Arabia, and the United Arab Emirates. The agreement grants SDS immediate rights to market and deploy Global e·dentity’s™ patented mobile AI...
-

Vouched Achieves Kantara Initiative Approval for NIST 800-63A Identity Assurance Level 2 (IAL2) Ready to Operate

SEATTLE--(BUSINESS WIRE)--Vouched, the leading provider of AI-powered identity verification, today announced it has received Ready to Operate (RTO) approval from the Kantara Initiative for NIST Special Publication 800-63A Identity Assurance Level 2 (IAL2). The certification confirms that Vouched’s identity proofing processes meet rigorous federal standards for verifying the identity of individuals in digital interactions, a critical requirement for regulated sectors including healthcare, financi...